Jointown Pharmaceutical Group Co Ltd Net Asset Quality Index
Jointown Pharmaceutical Group Co Ltd net asset quality index. Jointown Pharmaceutical Group Co Ltd (600998) has a Net Asset Quality Index of 31.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥112.28 Billion minus total liabilities of CN¥77.21 Billion yields net assets of CN¥35.07 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Jointown Pharmaceutical Group Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Jointown Pharmaceutical Group Co Ltd (2007–2024)
Net asset quality index of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. This chart shows how Jointown Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2007 to 2024. As of September 2025, the index stands at 31.2%, representing net assets of CN¥35.07 Billion against total assets of CN¥112.28 Billion CNY. See Jointown Pharmaceutical Group Co Ltd (600998) net assets for net asset value and shareholders' equity analysis.
Jointown Pharmaceutical Group Co Ltd Net Asset Quality Index by Year (2007–2024)
Jointown Pharmaceutical Group Co Ltd net asset quality index by year from 2007 to 2024. The table below presents the year-by-year Net Asset Quality Index for Jointown Pharmaceutical Group Co Ltd from 2007 to 2024, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Jointown Pharmaceutical Group Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 32.8% | CN¥33.59 Billion | CN¥102.40 Billion | CN¥68.80 Billion | ▲ +1.0 pp |
| 2023 | 31.8% | CN¥29.48 Billion | CN¥92.79 Billion | CN¥63.31 Billion | ▲ +0.7 pp |
| 2022 | 31.1% | CN¥28.69 Billion | CN¥92.27 Billion | CN¥63.59 Billion | ▼ -0.4 pp |
| 2021 | 31.5% | CN¥27.07 Billion | CN¥85.94 Billion | CN¥58.86 Billion | ▼ -0.2 pp |
| 2020 | 31.7% | CN¥25.62 Billion | CN¥80.82 Billion | CN¥55.21 Billion | ▲ +0.8 pp |
| 2019 | 30.9% | CN¥21.97 Billion | CN¥71.15 Billion | CN¥49.18 Billion | ▲ +0.3 pp |
| 2018 | 30.6% | CN¥20.38 Billion | CN¥66.67 Billion | CN¥46.29 Billion | ▼ -7.0 pp |
| 2017 | 37.5% | CN¥19.54 Billion | CN¥52.05 Billion | CN¥32.51 Billion | ▲ +6.5 pp |
| 2016 | 31.0% | CN¥12.01 Billion | CN¥38.73 Billion | CN¥26.72 Billion | ▲ +0.8 pp |
| 2015 | 30.2% | CN¥9.85 Billion | CN¥32.58 Billion | CN¥22.74 Billion | ▼ -3.3 pp |
| 2014 | 33.5% | CN¥8.09 Billion | CN¥24.13 Billion | CN¥16.04 Billion | ▲ +4.8 pp |
| 2013 | 28.7% | CN¥5.34 Billion | CN¥18.60 Billion | CN¥13.26 Billion | ▼ -4.0 pp |
| 2012 | 32.7% | CN¥4.84 Billion | CN¥14.80 Billion | CN¥9.97 Billion | ▼ -3.7 pp |
| 2011 | 36.4% | CN¥4.30 Billion | CN¥11.84 Billion | CN¥7.54 Billion | ▼ -12.9 pp |
| 2010 | 49.3% | CN¥4.00 Billion | CN¥8.12 Billion | CN¥4.12 Billion | ▲ +25.9 pp |
| 2009 | 23.3% | CN¥1.67 Billion | CN¥7.17 Billion | CN¥5.50 Billion | ▼ -2.5 pp |
| 2008 | 25.8% | CN¥1.48 Billion | CN¥5.72 Billion | CN¥4.24 Billion | ▼ -3.1 pp |
| 2007 | 28.9% | CN¥1.28 Billion | CN¥4.42 Billion | CN¥3.14 Billion | — |